These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 5759349)

  • 1. [Prognostic factors in stage II cervical cancer].
    Lacour J; Mourali N; Michel G
    Rev Fr Gynecol Obstet; 1968 Apr; 63(4):151-8. PubMed ID: 5759349
    [No Abstract]   [Full Text] [Related]  

  • 2. Validation of existing prognostic models in patients with early-stage cervical cancer.
    Biewenga P; van der Velden J; Mol BW; Stalpers LJ; Schilthuis MS; van der Steeg JW; Burger MP; Buist MR
    Gynecol Oncol; 2009 Nov; 115(2):277-84. PubMed ID: 19740531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone.
    Grigiene R; Valuckas KP; Aleknavicius E; Kurtinaitis J; Letautiene SR
    BMC Cancer; 2007 Dec; 7():234. PubMed ID: 18154683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic factors in uterine cervical and corpus cancer].
    Yoshioka T; Inoue Y; Hoshiai H; Noda K
    Gan To Kagaku Ryoho; 1995 Sep; 22(10):1417-22. PubMed ID: 7668881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors in cervical cancer].
    Hashimoto K; Hirabayashi K
    Saishin Igaku; 1971 Jan; 27(1):128-34. PubMed ID: 5141559
    [No Abstract]   [Full Text] [Related]  

  • 6. Difference in prognostic factors between stage IB and II uterine cervical carcinoma patients treated with radical hysterectomy and postoperative radiation therapy.
    Niibe Y; Karasawa K; Kaizu T; Mizutani K; Ozaki Y; Nagano H; Ueda K; Murakami A; Tanaka Y
    Radiat Med; 2002; 20(4):161-7. PubMed ID: 12296431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic significance of the clinical symptoms of cervical cancer].
    Zharinov GM
    Vopr Onkol; 1983; 29(10):38-42. PubMed ID: 6636618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation and treatment of cervical cancer].
    Morice P; Haie-Meder C; Lhommé C
    Rev Prat; 2001 Sep; 51(13):1432-8. PubMed ID: 11601072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic value of the clinical extension of cancer of the uterine cervix].
    Wolff JP; Rouquette C; Guilloux A
    Rev Fr Gynecol Obstet; 1968 Apr; 63(4):145-9. PubMed ID: 5759348
    [No Abstract]   [Full Text] [Related]  

  • 10. Vascular endothelial growth factor, matrix metalloproteinases, and cyclooxygenase-2 influence prognosis of uterine cervical cancer in young women.
    Noriyuki M; Sumi T; Zhi X; Misugi F; Nobeyama H; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
    Int J Oncol; 2007 Sep; 31(3):531-6. PubMed ID: 17671679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survival study of cervical cancer in Chennai, India.
    Gajalakshmi V; Rajaraman S; Shanta V
    Indian J Cancer; 2000 Dec; 37(4):158-64. PubMed ID: 12018568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biomarkers and uterine cervical cancer. Are they useful for prognosis of cancer and triage of precancerous lesions?].
    Salvat J; Schmidt MH; Vincent-Genod A; Slamani L; Martino A
    Contracept Fertil Sex; 1999; 27(7-8):521-31. PubMed ID: 10495569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
    Gadducci A; Tana R; Cosio S; Genazzani AR
    Crit Rev Oncol Hematol; 2008 Apr; 66(1):10-20. PubMed ID: 17964182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors of primary adenocarcinoma of the uterine cervix.
    Chen RJ; Chang DY; Yen ML; Lee EF; Huang SC; Chow SN; Hsieh CY
    Gynecol Oncol; 1998 May; 69(2):157-64. PubMed ID: 9600824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44v6 as a prognostic factor in cervical carcinoma FIGO stage IB.
    Bouda J; Boudova L; Hes O; Havir M; Tempfer C; Kohlberger P; Svoboda T; Rokyta Z; Speiser P
    Anticancer Res; 2005; 25(1B):617-22. PubMed ID: 15816636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pelvic irradiation-induced eosinophilia is correlated to prognosis of cervical cancer patients and transient elevation of serum interleukin 5 level.
    Yamazaki H; Inoue T; Tanaka E; Isohashi F; Koizumi M; Shuo X; Nakamura H; Inoue T
    Radiat Med; 2005 Aug; 23(5):317-21. PubMed ID: 16342902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
    Tsai CS; Lai CH; Wang CC; Chang JT; Chang TC; Tseng CJ; Hong JH
    Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the clinicopathological prognosis of stage IVb cervical carcinoma.
    Nishio S; Katsumata N; Matsumoto K; Tanabe H; Yonemori K; Kohno T; Shimizu C; Ando M; Kasamatsu T; Fujiwara Y
    Oncol Rep; 2008 Feb; 19(2):497-503. PubMed ID: 18202800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of 174 cases with cervical cancer in women under 35 years old].
    Zhang MQ; Chen MZ
    Zhonghua Fu Chan Ke Za Zhi; 2003 Nov; 38(11):689-93. PubMed ID: 14728859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors associated with recurrence in stage IB cervical carcinoma after radical hysterectomy and pelvic lymphadenectomy.
    Wilailak S; Tangtrakul S; Srisupundit S; Bullangpoti S; Linasmita V; Bhamarapravati Y
    J Med Assoc Thai; 1993 Jan; 76 Suppl 1():74-7. PubMed ID: 8113662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.